10 Best Falling Stocks to Invest in Right Now

Page 9 of 9

1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

52 Week Range: $666.25 – $1,211.20

Current Share Price: $680.03

Number of Hedge Fund Holders: 62

Stock Upside Potential: 48.14%

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) discovers, develops, manufactures, and commercializes medicines for treating various diseases. The company’s lead products include Eylea injection for treating wet age-related macular degeneration and diabetic macular edema. The company was under immense pressure, dropping by 27% in 2024.

The underperformance came as investors reacted to the company’s lead product, Eylea, facing stiff competition from Roche’s Vabysmo. The issue was further exacerbated by biosimilar competition, Amgen having won the right to launch its biosimilar version for Eylea. Amid the stiff competition, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) delivered solid third-quarter results, with revenues increasing 11% year over year.

Additionally, the company moved to strengthen its competitive edge by developing a high-dose formulation for Eylea. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) succeeded in taking the fight to Roche by decreasing the number of annual injections. The company’s other growth driver, Dupixent, is also doing well, helping shrug off sales slowdown in different drugs. The fact that the US Food and Drug Administration has approved using Dupixent to treat COPD positions Regeneron to generate billions of dollars in annual sales. Dupixent has the potential to strengthen Regeneron’s revenue base, given that the COPD indication market is still fresh.

As we acknowledge the growth potential of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than REGN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9